Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 141

1.

Glucocorticoid, immunosuppressant, hydroxychloroquine monotherapy, or no therapy for maintenance treatment in systemic lupus erythematosus without major organ manifestations.

Hanaoka H, Iida H, Kiyokawa T, Takakuwa Y, Kawahata K.

Clin Rheumatol. 2019 Jun 7. doi: 10.1007/s10067-019-04633-y. [Epub ahead of print]

PMID:
31175481
2.

High plasma mycophenolate acid concentration in the early phase of induction therapy predicts good renal outcome in lupus nephritis.

Kiyokawa T, Hanaoka H, Iida H, Ishimori K, Takakuwa Y, Okazaki T, Ozaki S, Kawahata K.

Mod Rheumatol. 2019 Jun 13:1-8. doi: 10.1080/14397595.2019.1623435. [Epub ahead of print]

PMID:
31135249
3.

Anti-IL-10 antibody in systemic lupus erythematosus.

Uchida M, Ooka S, Goto Y, Suzuki K, Fujimoto H, Ishimori K, Matsushita H, Takakuwa Y, Kawahata K.

Open Access Rheumatol. 2019 Mar 26;11:61-65. doi: 10.2147/OARRR.S191953. eCollection 2019.

4.

Corticosteroid dose increase is a risk factor for nonalcoholic fatty liver disease and contralateral osteonecrosis of the femoral head: a case report.

Shimizu H, Shimizu T, Takahashi D, Asano T, Arai R, Takakuwa Y, Iwasaki N.

BMC Musculoskelet Disord. 2019 Feb 19;20(1):88. doi: 10.1186/s12891-019-2468-5.

5.

Adult-onset Still's disease-associated interstitial lung disease represents severe phenotype of the disease with higher rate of haemophagocytic syndrome and relapse.

Takakuwa Y, Hanaoka H, Kiyokawa T, Iida H, Ishimori K, Uekusa T, Yamada H, Kawahata K.

Clin Exp Rheumatol. 2019 Feb 11. [Epub ahead of print]

PMID:
30767871
6.

A low perfusion-metabolic mismatch in 99m Tl and 123 I-BMIPP scintigraphy predicts poor prognosis in systemic sclerosis patients with asymptomatic cardiac involvement.

Iida H, Hanaoka H, Okada Y, Kiyokawa T, Takakuwa Y, Yamada H, Okazaki T, Ozaki S, Yamaguchi K, Nakajima Y, Kawahata K.

Int J Rheum Dis. 2019 Feb 6. doi: 10.1111/1756-185X.13508. [Epub ahead of print]

PMID:
30729690
7.

Low-dose rituximab as induction therapy for ANCA-associated vasculitis.

Takakuwa Y, Hanaoka H, Kiyokawa T, Iida H, Fujimoto H, Yamasaki Y, Yamada H, Kawahata K.

Clin Rheumatol. 2019 Apr;38(4):1217-1223. doi: 10.1007/s10067-019-04443-2. Epub 2019 Jan 25.

PMID:
30680533
8.

Hydroxychloroquine Improves the Disease Activity and Allows the Reduction of the Corticosteroid Dose Regardless of Background Treatment in Japanese Patients with Systemic Lupus Erythematosus.

Hanaoka H, Iida H, Kiyokawa T, Takakuwa Y, Kawahata K.

Intern Med. 2019 May 1;58(9):1257-1262. doi: 10.2169/internalmedicine.1999-18. Epub 2019 Jan 10.

9.

Low additive effect of hydroxychloroquine on Japanese patients with systemic lupus erythematosus taking calcineurin inhibitor.

Hanaoka H, Iida H, Kiyokawa T, Takakuwa Y, Kawahata K.

Int J Rheum Dis. 2019 Mar;22(3):468-472. doi: 10.1111/1756-185X.13418. Epub 2018 Nov 8.

PMID:
30406967
10.

A positive direct Coombs' test in the absence of hemolytic anemia predicts high disease activity and poor renal response in systemic lupus erythematosus.

Hanaoka H, Iida H, Kiyokawa T, Takakuwa Y, Kawahata K.

Lupus. 2018 Dec;27(14):2274-2278. doi: 10.1177/0961203318809182. Epub 2018 Oct 25.

PMID:
30354857
11.

Mycophenolate mofetil treatment with or without a calcineurin inhibitor in resistant inflammatory myopathy.

Hanaoka H, Iida H, Kiyokawa T, Takakuwa Y, Kawahata K.

Clin Rheumatol. 2019 Feb;38(2):585-590. doi: 10.1007/s10067-018-4294-9. Epub 2018 Sep 14.

PMID:
30218287
12.

Histopathological differences of experimental aneurysms treated with bare platinum, fibered, and bioactive coils.

Usami Y, Hirokawa N, Saitoh M, Okuda H, Someya M, Hasegawa T, Takakuwa Y, Sakata KI.

Minim Invasive Ther Allied Technol. 2019 Jun;28(3):172-177. doi: 10.1080/13645706.2018.1499532. Epub 2018 Aug 16.

PMID:
30113870
13.

Renal protective effect of antiplatelet therapy in antiphospholipid antibody-positive lupus nephritis patients without antiphospholipid syndrome.

Hanaoka H, Iida H, Kiyokawa T, Takakuwa Y, Okazaki T, Yamada H, Ozaki S, Kawahata K.

PLoS One. 2018 May 3;13(5):e0196172. doi: 10.1371/journal.pone.0196172. eCollection 2018.

14.

Early achievement of deep remission predicts low incidence of renal flare in lupus nephritis class III or IV.

Hanaoka H, Iida H, Kiyokawa T, Takakuwa Y, Kawahata K.

Arthritis Res Ther. 2018 May 2;20(1):86. doi: 10.1186/s13075-018-1576-1. No abstract available.

15.

Whole genome analysis of a multidrug-resistant Streptococcus pneumoniae isolate from a patient with invasive pneumococcal infection developing disseminated intravascular coagulation.

Ohkoshi Y, Sato T, Wada T, Fukushima Y, Murabayashi H, Takakuwa Y, Nishiyama K, Honda H, Shiraishi T, Kuronuma K, Takahashi H, Nakajima C, Suzuki Y, Yokota SI.

J Infect Chemother. 2018 Aug;24(8):674-681. doi: 10.1016/j.jiac.2018.01.012. Epub 2018 Feb 26.

PMID:
29496334
16.

Band 3 phosphorylation induces irreversible alterations of stored red blood cells.

Azouzi S, Romana M, Arashiki N, Takakuwa Y, El Nemer W, Peyrard T, Colin Y, Amireault P, Le Van Kim C.

Am J Hematol. 2018 May;93(5):E110-E112. doi: 10.1002/ajh.25044. Epub 2018 Feb 24. No abstract available.

17.

Extracorporeal Shock Wave Therapy for Coronary Artery Disease: Relationship of Symptom Amelioration and Ischemia Improvement.

Takakuwa Y, Sarai M, Kawai H, Yamada A, Shiino K, Takada K, Nagahara Y, Miyagi M, Motoyama S, Toyama H, Ozaki Y.

Asia Ocean J Nucl Med Biol. 2018 Winter;6(1):1-9. doi: 10.22038/aojnmb.2017.9899.

18.

Complete Genome Sequence of Multidrug-Resistant Streptococcus pneumoniae Serotype 19F Isolated from an Invasive Infection in Sapporo, Japan.

Sato T, Ohkoshi Y, Wada T, Fukushima Y, Murabayashi H, Takakuwa Y, Nishiyama K, Shiraishi T, Nakajima C, Suzuki Y, Yokota SI.

Genome Announc. 2017 Nov 2;5(44). pii: e01239-17. doi: 10.1128/genomeA.01239-17.

19.

Rhabdomyolysis in a Patient with Polyarteritis Nodosa.

Iida H, Hanaoka H, Asari Y, Ishimori K, Kiyokawa T, Takakuwa Y, Yamasaki Y, Yamada H, Okazaki T, Doi M, Ozaki S.

Intern Med. 2018 Jan 1;57(1):101-106. doi: 10.2169/internalmedicine.8913-17. Epub 2017 Oct 11.

20.

Comparison of renal response to four different induction therapies in Japanese patients with lupus nephritis class III or IV: A single-centre retrospective study.

Hanaoka H, Kiyokawa T, Iida H, Ishimori K, Takakuwa Y, Okazaki T, Yamada H, Ichikawa D, Shirai S, Koike J, Ozaki S.

PLoS One. 2017 Apr 6;12(4):e0175152. doi: 10.1371/journal.pone.0175152. eCollection 2017.

21.

Maintenance and regulation of asymmetric phospholipid distribution in human erythrocyte membranes: implications for erythrocyte functions.

Arashiki N, Takakuwa Y.

Curr Opin Hematol. 2017 May;24(3):167-172. doi: 10.1097/MOH.0000000000000326. Review.

PMID:
28118222
22.

Recurrent Bilateral Focal Myositis.

Nagafuchi H, Nakano H, Ooka S, Takakuwa Y, Yamada H, Tadokoro M, Shimojo S, Ozaki S.

Intern Med. 2016;55(22):3369-3374. Epub 2016 Nov 15.

23.

Two Cases of Chronic Gastritis with non-Helicobacter pylori Helicobacter Infection.

Shiratori S, Mabe K, Yoshii S, Takakuwa Y, Sato M, Nakamura M, Kudo T, Kato M, Asaka M, Sakamoto N.

Intern Med. 2016;55(14):1865-9. doi: 10.2169/internalmedicine.55.5891. Epub 2016 Jul 15.

24.

Hypertrophic Cardiomyopathy Accompanied by Spinocerebellar Atrophy With a Novel Mutation in Troponin I Gene.

Kawai H, Morimoto S, Takakuwa Y, Ueda A, Inada K, Sarai M, Arimura T, Mutoh T, Kimura A, Ozaki Y.

Int Heart J. 2016 Jul 27;57(4):507-10. doi: 10.1536/ihj.15-444. Epub 2016 Jul 7.

25.

An Unrecognized Function of Cholesterol: Regulating the Mechanism Controlling Membrane Phospholipid Asymmetry.

Arashiki N, Saito M, Koshino I, Kamata K, Hale J, Mohandas N, Manno S, Takakuwa Y.

Biochemistry. 2016 Jun 28;55(25):3504-3513. doi: 10.1021/acs.biochem.6b00407. Epub 2016 Jun 13.

26.

Eicosapentaenoic acid to arachidonic acid (EPA/AA) ratio as an associated factor of high risk plaque on coronary computed tomography in patients without coronary artery disease.

Nagahara Y, Motoyama S, Sarai M, Ito H, Kawai H, Takakuwa Y, Miyagi M, Shibata D, Takahashi H, Naruse H, Ishii J, Ozaki Y.

Atherosclerosis. 2016 Jul;250:30-7. doi: 10.1016/j.atherosclerosis.2016.04.026. Epub 2016 Apr 27.

PMID:
27175609
27.
28.

ATP11C is a major flippase in human erythrocytes and its defect causes congenital hemolytic anemia.

Arashiki N, Takakuwa Y, Mohandas N, Hale J, Yoshida K, Ogura H, Utsugisawa T, Ohga S, Miyano S, Ogawa S, Kojima S, Kanno H.

Haematologica. 2016 May;101(5):559-65. doi: 10.3324/haematol.2016.142273. Epub 2016 Mar 4.

29.

Longitudinal PBL in Undergraduate Medical Education Develops Lifelong-Learning Habits and Clinical Competencies in Social Aspects.

Okubo Y, Matsushita S, Takakuwa Y, Yoshioka T, Nitta K.

Tohoku J Exp Med. 2016 Feb;238(2):185. doi: 10.1620/tjem.238.185. No abstract available.

30.

Longitudinal PBL in Undergraduate Medical Education Develops Lifelong-Learning Habits and Clinical Competencies in Social Aspects.

Okubo Y, Matsushita S, Takakuwa Y, Yoshioka T, Nitta K.

Tohoku J Exp Med. 2016 Jan;238(1):65-74. doi: 10.1620/tjem.238.65. Erratum in: Tohoku J Exp Med. 2016;238(2):185.

31.

Altered acetylation of proteins in patients with rheumatoid arthritis revealed by acetyl-proteomics.

Arito M, Nagai K, Ooka S, Sato T, Takakuwa Y, Kurokawa MS, Sase T, Okamoto K, Suematsu N, Kato T.

Clin Exp Rheumatol. 2015 Nov-Dec;33(6):877-86. Epub 2015 Oct 27.

PMID:
26517718
32.

Clinical subsets associated with different anti-aminoacyl transfer RNA synthetase antibodies and their association with coexisting anti-Ro52.

Yamasaki Y, Satoh M, Mizushima M, Okazaki T, Nagafuchi H, Ooka S, Shibata T, Nakano H, Ogawa H, Azuma K, Maeda A, Tonooka K, Ito H, Takakuwa Y, Inoue M, Mitomi H, Kiyokawa T, Tsuchida K, Matsushita H, Mikage H, Murakami Y, Chan JY, Ozaki S, Yamada H.

Mod Rheumatol. 2016;26(3):403-9. doi: 10.3109/14397595.2015.1091155. Epub 2015 Oct 19.

PMID:
26344678
33.

Two cases with past Kawasaki disease developing acute myocardial infarction in their thirties, despite being regarded as at low risk for coronary events.

Kawai H, Takakuwa Y, Naruse H, Sarai M, Motoyama S, Ito H, Iwase M, Ozaki Y.

Heart Vessels. 2015 Jul;30(4):549-53. doi: 10.1007/s00380-014-0541-4. Epub 2014 Jul 2.

PMID:
24985931
34.

[Senescence mechanism of human erythrocytes].

Takakuwa Y, Arashiki N, Saito M.

Rinsho Ketsueki. 2014 Jun;55(6):643-50. Japanese. No abstract available.

PMID:
24975333
35.

Cortical bone remodeling in parosteal osteosarcoma mimicking medullary involvement: a case with the difficulty in pre-surgical staging.

Shimoyama T, Yamamoto Y, Kuroda M, Takakuwa Y, Washimi Y, Ishimura D, Yamada H.

Tohoku J Exp Med. 2014 Jul;233(3):165-9.

36.

Phosphatidylinositol-4,5 bisphosphate (PIP(2)) inhibits apo-calmodulin binding to protein 4.1.

Nunomura W, Gascard P, Wakui H, Takakuwa Y.

Biochem Biophys Res Commun. 2014 Apr 4;446(2):434-40. doi: 10.1016/j.bbrc.2014.02.121. Epub 2014 Mar 6.

PMID:
24607279
37.

Protein profiles of peripheral blood mononuclear cells as a candidate biomarker for Behçet's disease.

Yoshioka T, Kurokawa MS, Sato T, Nagai K, Iizuka N, Arito M, Takakuwa Y, Nakano H, Ooka S, Suematsu N, Okamoto K, Yudoh K, Nakamura H, Suzuki N, Ozaki S, Kato T.

Clin Exp Rheumatol. 2014 Jul-Aug;32(4 Suppl 84):S9-19. Epub 2013 Nov 14.

PMID:
24237878
38.

Development of an amorphous selenium-based photodetector driven by a diamond cold cathode.

Masuzawa T, Saito I, Yamada T, Onishi M, Yamaguchi H, Suzuki Y, Oonuki K, Kato N, Ogawa S, Takakuwa Y, Koh AT, Chua DH, Mori Y, Shimosawa T, Okano K.

Sensors (Basel). 2013 Oct 11;13(10):13744-78. doi: 10.3390/s131013744. Review.

39.

Unique structural changes in calcium-bound calmodulin upon interaction with protein 4.1R FERM domain: novel insights into the calcium-dependent regulation of 4.1R FERM domain binding to membrane proteins by calmodulin.

Nunomura W, Isozumi N, Nakamura S, Jinbo Y, Ohki S, Kidokoro S, Wakui H, Takakuwa Y.

Cell Biochem Biophys. 2014 May;69(1):7-19. doi: 10.1007/s12013-013-9758-6.

PMID:
24081810
40.

Comparative proteomic analysis of neutrophils from patients with microscopic polyangiitis and granulomatosis with polyangiitis.

Uchida T, Nagai K, Sato T, Iizuka N, Arito M, Takakuwa Y, Nakano H, Ooka S, Kurokawa MS, Suematsu N, Okamoto K, Ozaki S, Kato T.

J Proteomics. 2013 Oct 8;91:259-69. doi: 10.1016/j.jprot.2013.07.021. Epub 2013 Aug 2.

PMID:
23911962
41.

Membrane peroxidation and methemoglobin formation are both necessary for band 3 clustering: mechanistic insights into human erythrocyte senescence.

Arashiki N, Kimata N, Manno S, Mohandas N, Takakuwa Y.

Biochemistry. 2013 Aug 27;52(34):5760-9. doi: 10.1021/bi400405p. Epub 2013 Aug 16.

42.

Novel mechanism of regulation of protein 4.1G binding properties through Ca2+/calmodulin-mediated structural changes.

Nunomura W, Jinbo Y, Isozumi N, Ohki S, Izumi Y, Matsushima N, Takakuwa Y.

Cell Biochem Biophys. 2013 Jul;66(3):545-58. doi: 10.1007/s12013-012-9502-7.

PMID:
23354586
43.

Identification of a novel role for dematin in regulating red cell membrane function by modulating spectrin-actin interaction.

Koshino I, Mohandas N, Takakuwa Y.

J Biol Chem. 2012 Oct 12;287(42):35244-50. doi: 10.1074/jbc.M111.305441. Epub 2012 Aug 26.

44.

Altered posttranslational modification on U1 small nuclear ribonucleoprotein 68k in systemic autoimmune diseases detected by 2D Western blot.

Nagai K, Arito M, Takakuwa Y, Ooka S, Sato T, Kurokawa MS, Okamoto K, Uchida T, Suematsu N, Kato T.

Electrophoresis. 2012 Jul;33(13):2028-35. doi: 10.1002/elps.201200058.

PMID:
22806469
45.

Characterization of cytoskeletal protein 4.1R interaction with NHE1 (Na(+)/H(+) exchanger isoform 1).

Nunomura W, Denker SP, Barber DL, Takakuwa Y, Gascard P.

Biochem J. 2012 Sep 15;446(3):427-35. doi: 10.1042/BJ20120535.

47.

Dynamic secondary structural changes in Ca²⁺-saturated calmodulin upon interaction with the antagonist, W-7.

Sasakura D, Nunomura W, Takakuwa Y.

Biochem Biophys Res Commun. 2012 Jun 29;423(2):360-5. doi: 10.1016/j.bbrc.2012.05.131. Epub 2012 Jun 1.

PMID:
22664109
48.

Intracellular interactions between protein 4.1 and glycophorin C on transport vesicles, as determined by fluorescence correlation spectroscopy.

Tanaka S, Takakuwa Y.

FEBS Lett. 2012 Mar 23;586(6):668-74. doi: 10.1016/j.febslet.2012.01.058. Epub 2012 Feb 9.

49.

Cutaneous polyarteritis nodosa associated with HLA-B39-positive undifferentiated spondyloarthritis in a Japanese patient.

Nakano H, Ooka S, Shibata T, Ogawa H, Ito H, Takakuwa Y, Tonooka K, Maeda A, Yamasaki Y, Kiyokawa T, Nagafuchi H, Yamada H, Ozaki S.

Mod Rheumatol. 2012 Sep;22(5):783-6. doi: 10.1007/s10165-011-0576-7. Epub 2012 Jan 21.

PMID:
22270344
50.

Enucleation of human erythroblasts involves non-muscle myosin IIB.

Ubukawa K, Guo YM, Takahashi M, Hirokawa M, Michishita Y, Nara M, Tagawa H, Takahashi N, Komatsuda A, Nunomura W, Takakuwa Y, Sawada K.

Blood. 2012 Jan 26;119(4):1036-44. doi: 10.1182/blood-2011-06-361907. Epub 2011 Nov 2.

Supplemental Content

Loading ...
Support Center